Fees in Respect of Drugs and Medical Devices Order

Marginal note:Remission — designated COVID-19 drug

• 14.1 (1) Remission is granted to the person referred to in subsection 9(2) of the amount of the fee that is payable under subsection 9(1) if the person has

  • (a) filed an application for a designated COVID-19 drug under the ISAD Interim Order; and

  • (b) subsequently filed a submission for that drug.

• Marginal note:Remission — no previous submission

  (2) The remission referred to in subsection (1) is granted if the person has not previously filed a submission for the designated COVID-19 drug.